CCS Medical
CCS Medical is a U.S. durable medical equipment distributor and chronic care management company that delivers continuous glucose monitors, insulin pumps, and supplies to more than 200,000 diabetes patients, augmented by the LivingConnected clinical platform and proprietary PropheSee and CeeCee AI tools for adherence and engagement.
- Company typePrivate
- Founded1994
- HeadquartersFarmers Branch, United States
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingServices
CCS Medical firmographics
Firmographics- Name
- CCS Medical
- Legal name
- CCS Medical, Inc.
- Website
- https://ccsmed.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- CCS Medical is a U.S. durable medical equipment distributor and chronic care management company that delivers continuous glucose monitors, insulin pumps, and supplies to more than 200,000 diabetes patients, augmented by the LivingConnected clinical platform and proprietary PropheSee and CeeCee AI tools for adherence and engagement.
- Ownership category
- akta.pro rank
CCS Medical industry classification
Industry- Product category
- Chronic Care Management
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Durable Medical Equipment (DME) & Home Health Distribution (CRAOAHAF)
- akta.pro secondary industries
- Continuous Glucose Monitoring (CGM) Systems (HLAHAHAA), Automated Insulin Delivery (AID) / Closed-Loop Systems (HLAHAHAF)
Keywords
Where CCS Medical is headquartered
LocationHeadquarters
- HQ city
- Farmers Branch
- HQ country
- United States
- HQ region
- North America
Offices9 records
Markets served
CCS Medical business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Medical Supplies Distribution: CCS generates revenue primarily through the distribution of durable medical equipment (DME) including CGM systems, insulin pumps, and related supplies. Revenue is derived from insurance reimbursements from Medicare, Medicaid, and commercial health plans. The company is contracted with over 1800 in-network care plans.
- Clinical Services & Coaching: Revenue generated from clinical education, monitoring, and coaching programs (LivingConnected®) offered to health plans and employers as part of diabetes care management contracts.
- Data-Driven Care Partnerships: Partnership revenue streams from collaborations with health plans and manufacturers focused on improving therapy adherence and patient outcomes through CCS's technology platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Monthly | Standard insurance-covered supply delivery with clinical support |
| Unit Pricing | Pay-as-you-go | Expedited shipping option |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
CCS Medical product offering
Product offeringCore offering
CCS Medical distributes continuous glucose monitors (CGM), insulin pumps, and diabetes supplies directly to patients' homes as a Durable Medical Equipment (DME) supplier, while bundling clinical education, real-time monitoring, and coaching through its LivingConnected® program. The company also offers enterprise-level AI platforms — CeeCee™ (agentic AI) and PropheSee™ (predictive analytics) — sold to health plans, employers, and providers to drive therapy adherence and reduce the cost of diabetes complications.
Product overview
CCS Medical is a chronic care management organization providing a comprehensive portfolio of medical supplies and clinical programs for diabetes management. The core product portfolio includes CGM systems (Abbott FreeStyle Libre 2/3/Plus variants, Dexcom G7/15-Day) and insulin pumps (Beta Bionics iLet, Insulet Omnipod®5) for home delivery. The LivingConnected® clinical care platform integrates these devices with education, monitoring, and coaching services. AI-powered solutions include CeeCee™ (agentic AI for autonomous patient engagement) and PropheSee™ (predictive analytics for adherence intervention), which together form an enterprise-level AI system unique in the diabetes distribution industry. The LivingConnected® with Gestational Diabetes program extends specialized care to expectant mothers. With 30 years of experience, 200K+ patients on service, and partnerships with 1800+ in-network care plans, CCS delivers products, education, and AI-driven support as a unified chronic care solution.
Differentiator
Problem solved
Functional benefit
Brands
- LivingConnected®: Evidence-based clinical program integrating device delivery with comprehensive education, monitoring, and personalized coaching for diabetes management.
- CeeCee™
- PropheSee™
- LivingConnected® with Gestational Diabetes
Products and services
- Abbott FreeStyle Libre 2 System Continuous glucose monitoring system with optional glucose alarms and wear time up to 14 days, distributed to diabetes patients via CCS Medical's home-delivery DME service.
- Abbott FreeStyle Libre 2 Plus System CGM system with automatic readings every minute and enhanced features for glucose monitoring, distributed to diabetes patients via CCS Medical.
- Abbott FreeStyle Libre 3 System Smallest, most discreet CGM system with real-time glucose readings sent directly to a smartphone, distributed via CCS Medical's DME service.
- Abbott FreeStyle Libre 3 Plus System CGM system with longer wear time and enhanced accuracy for continuous glucose monitoring, distributed via CCS Medical.
- Beta Bionics iLet Bionic Pancreas Fully automated insulin dosing system that acts as a bionic pancreas for diabetes management, distributed by CCS Medical.
- Dexcom G7 15 Day CGM System Advanced CGM system approximately 60% smaller than previous Dexcom models with 15-day wear, distributed via CCS Medical.
- Dexcom G7 CGM System Next-generation continuous glucose monitoring system with improved accuracy and user experience, distributed via CCS Medical.
- Insulet Omnipod® 5 Tubeless, water-resistant insulin pump with SmartAdjust™ technology for automated insulin delivery, distributed by CCS Medical.
- LivingConnected® Clinical Care Program Evidence-based clinical care program integrating device delivery with comprehensive diabetes education, real-time monitoring, and personalized coaching by Certified Diabetes Educators, sold to health plans, employers, and patients.
- LivingConnected® with Gestational Diabetes Specialty clinical care management program for expectant mothers with gestational diabetes, providing breast pump services, lactation consulting, nutrition coaching, and remote blood glucose monitoring.
- CeeCee™ Enterprise Agentic AI Platform Enterprise-level agentic AI platform that autonomously interacts with patients and providers, anticipating needs, automating routine tasks and communications, and delivering personalized support at every touchpoint.
- PropheSee™ Predictive Analytics Platform Proprietary AI-powered predictive analytics and intervention platform that forecasts CGM therapy discontinuation with 85% accuracy within a 90-day forward window, delivering hyper-personalized interventions to drive therapy adherence, sold to health plans, employers, and providers.
Quantifiable outcome
- 50% improvement in test versus control adherence outcomes through PropheSee™ deployment
- +4 more outcomes
Companies that use CCS Medical
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
CCS Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability7 records
Feature4 records
CCS Medical partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Adaptive MLcorePartnership to accelerate generative AI development using reinforcement learning. Adaptive ML helped CCS develop its CeeCee agentic AI platform using Meta Llama and AWS infrastructure. Collaboration enables autonomous patient support and operational efficiency.
- SweetSpotcoreStrategic partnership to expand access to data-driven remote care for people with diabetes. Collaboration aims to improve healthcare delivery through data access and remote monitoring, combining CCS's supply distribution and clinical programs with SweetSpot's data capabilities.
- Parachute HealthcoreTechnology partnership for ePrescribing that eliminates faxing and paper-based ordering. Parachute Health platform provides frictionless order experience with end-to-end tracking, empowering providers to focus on patient care rather than paperwork.
- AccenturecoreCollaboration on developing PropheSee™ predictive analytics model. Accenture contributed data science expertise to build the platform that identifies patients at risk of non-adherence up to 90 days in advance, enabling personalized interventions.
- United Regional Health Care SystemminorHealthcare system partnership providing LivingConnected® diabetes education program to employees, demonstrating employer-focused GTM for diabetes care management solutions.
Scale indicators11 records
Recent moves6 records
Expansion highlights6 records
CCS Medical competitors and assessment
Company assessmentDirect peers
- Edgepark Medical Supplies: Edgepark is a long-standing national DME supplier serving patients with diabetes and other chronic conditions via home delivery, insurance billing, and provider referrals — directly comparable to CCS's distribution-led GTM.
- Solara Medical Supplies: Solara is a privately held DME distributor focused on diabetes CGMs, insulin pumps, and supplies, competing with CCS for the same manufacturer partnerships, payer contracts, and direct-to-patient home delivery relationships.
- US Med: US Med is one of the largest privately held DME distributors focused exclusively on diabetes supplies, CGMs, and insulin pumps, competing head-to-head with CCS for manufacturer distribution rights, payer contracts, and patient referrals in the same US channels.
- Byram Healthcare: Byram Healthcare is a national DME distributor (now part of Owens & Minor) with a substantial diabetes supply business, offering direct home delivery, insurance billing, and clinical support services that overlap directly with CCS's core distribution-plus-coaching model.
- 180 Medical: 180 Medical is a national DME distributor specializing in chronic-condition supplies with direct home delivery and insurance verification capabilities — operating a comparable distribution-plus-patient-services model in adjacent categories.
Broad incumbents
- Dexcom: Dexcom is a leading CGM manufacturer and a current distribution partner of CCS. It is also a broad incumbent actively investing in direct-to-patient fulfillment, which positions it as both a partner and a structural threat to third-party DME distributors like CCS.
- Teladoc Health (Livongo): Teladoc acquired Livongo and now offers enterprise chronic condition management (including diabetes) at scale to employers and health plans — a broader incumbent competing for the same value-based chronic care contracts CCS targets with LivingConnected® and PropheSee™.
- AdaptHealth: AdaptHealth is a publicly traded, multi-category DME provider with a large diabetes supply business alongside sleep, respiratory, and home medical equipment. It is a much broader incumbent that competes with CCS in diabetes distribution while also offering payers a one-stop DME solution.
Emerging players
- Omada Health: Omada is a digital chronic care management platform serving employers and payers with diabetes, hypertension, and musculoskeletal programs, competing with LivingConnected® for the same enterprise buyer and overlapping with CCS on virtual coaching and outcomes-based contracts.
Others
- Welldoc: Welldoc powers the LivingConnected® platform and offers its own FDA-cleared digital diabetes therapeutic (BlueStar). It is a current technology partner of CCS but also a potential competitor as payers and IDNs adopt standalone digital diabetes solutions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
CCS Medical social profiles
Digital presenceCCS Medical compliance and trust
Trust signalCompliance8 records
CCS Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
CCS Medical leadership team
Management profileNumber of profiles
Profiles6 records
CCS Medical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CCS Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CCS Medical
What does CCS Medical do?
CCS Medical distributes continuous glucose monitors (CGM), insulin pumps, and diabetes supplies directly to patients' homes as a Durable Medical Equipment (DME) supplier, while bundling clinical education, real-time monitoring, and coaching through its LivingConnected® program. The company also offers enterprise-level AI platforms — CeeCee™ (agentic AI) and PropheSee™ (predictive analytics) — sold to health plans, employers, and providers to drive therapy adherence and reduce the cost of diabetes complications.
Is CCS Medical a public or private company?
CCS Medical is a private company. It is classified as unknown and is currently operating.
When was CCS Medical founded?
CCS Medical was founded in 1994. It employs 1,001 to 5,000 people.
Where is CCS Medical based?
CCS Medical is headquartered in Farmers Branch, United States, in the North America region.
How does CCS Medical make money?
Three revenue lines are on record. Medical Supplies Distribution is the primary driver. The others are clinical Services & Coaching and data-Driven Care Partnerships.
Who are CCS Medical's main competitors?
Direct peers on record are Edgepark Medical Supplies, Solara Medical Supplies, US Med, Byram Healthcare and 180 Medical. Broad incumbents are Dexcom, Teladoc Health (Livongo) and AdaptHealth. Omada Health is listed as an emerging player. Welldoc is listed as an others.
Does CCS Medical have an API?
No public API is recorded for CCS Medical.
What industry is CCS Medical in?
CCS Medical's product category is Chronic Care Management. Its primary akta.pro industry code is CRAOAHAF, Durable Medical Equipment (DME) & Home Health Distribution, with a secondary code of HLAHAHAA, Continuous Glucose Monitoring (CGM) Systems. Its SIC code is 5047.